Cargando…
Imaging Effector Memory T-Cells Predicts Response to PD1-Chemotherapy Combinations in Colon Cancer
Often, patients fail to respond to immune checkpoint inhibitor (ICI) treatment despite favourable biomarker status. Numerous chemotherapeutic agents have been shown to promote tumour immunogenicity when used in conjunction with ICIs; however, little is known about whether such combination therapies...
Autores principales: | Goggi, Julian L., Khanapur, Shivashankar, Hartimath, Siddesh V., Ramasamy, Boominathan, Cheng, Peter, Chin, Hui-Xian, Tang, Jun-Rong, Hwang, You-Yi, Robins, Edward G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598730/ https://www.ncbi.nlm.nih.gov/pubmed/36289605 http://dx.doi.org/10.3390/biomedicines10102343 |
Ejemplares similares
-
Imaging Memory T-Cells Stratifies Response to Adjuvant Metformin Combined with αPD-1 Therapy
por: Goggi, Julian L., et al.
Publicado: (2022) -
Granzyme B PET Imaging in Response to In Situ Vaccine Therapy Combined with αPD1 in a Murine Colon Cancer Model
por: Hartimath, Siddesh V., et al.
Publicado: (2022) -
An Improved Synthesis of N-(4-[(18)F]Fluorobenzoyl)-Interleukin-2 for the Preclinical PET Imaging of Tumour-Infiltrating T-cells in CT26 and MC38 Colon Cancer Models
por: Khanapur, Shivashankar, et al.
Publicado: (2021) -
Imaging Adipose Tissue Browning using Mitochondrial Complex-I Tracer [(18)F]BCPP-EF
por: Goggi, Julian L., et al.
Publicado: (2022) -
Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer
por: Goggi, Julian L, et al.
Publicado: (2021)